Pfizer Inc. plans to stop enrollment in a study of its COVID-19 drug in patients who aren’t at high risk of severe disease after the pill didn’t help alleviate their symptoms, a major setback ...

The Pfizer “Breakthrough Fellowship” is described by the pharmaceutical giant as a “first of its kind” program that will work to “advance students and early career colleagues of Black ...

Though many worked from home during the vaccine's development, Pfizer's culture was "banked" from years of in-person work, she said. Some companies have recently faced backlash for requiring in ...